GMPs On Tour: FDA Briefs EU, Japan To Avoid Trade Issues From New Rules
Executive Summary
FDA is explaining its new good manufacturing practice regulations to regulatory officials in other countries to minimize disruptions in trade once they are implemented
You may also be interested in...
GMP Quality Management Systems For FDA Will Be Proposed By December
FDA expects to release a draft on improving the agency's good manufacturing practices management systems by Dec. 1
FDA And EMEA To Compare Regulatory Approaches Used In 1998 NME Cohort
FDA and the European Medicines Evaluation Agency will conduct a joint assessment of the approaches used by the two agencies in the 1998 cohort of new molecular entity reviews.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011